Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries.
Schnyder
Guido
G
Division of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Switzerland. g.schnyder@lycos.com
Roffi
Marco
M
Flammer
Yvonne
Y
Pin
Riccardo
R
Eberli
Franz R
FR
Meier
Bernhard
B
Turi
Zoltan G
ZG
Hess
Otto M
OM
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000097:blood / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects* / Q000601:surgery; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015607:Stents; D014805:Vitamin B 12 / Q000627:therapeutic use; D025101:Vitamin B 6 / Q000627:therapeutic use
D006710:Homocysteine; D025101:Vitamin B 6; D005492:Folic Acid; D014805:Vitamin B 12